INS and diabetes mellitus: Thus, pancreas-targeted CLU OE causes metabolic deregulation being evident by altered expression of mitochondrial and metabolic genes, along with exaggeration of diabetic phenotypes as manifested by decreased GLU, INS and PYR tolerance in basal conditions or in a model of STZ-induced diabetes.